Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:2751-2757

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manning, B. S.
Right arrow Articles by Koch, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manning, B. S.
Right arrow Articles by Koch, W. J.
Related Collections
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Heart failure - basic studies
Right arrow Hypertrophy
Right arrow Gene therapy

(Circulation. 2000;102:2751.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Physiological Induction of a ß-Adrenergic Receptor Kinase Inhibitor Transgene Preserves ß-Adrenergic Responsiveness in Pressure-Overload Cardiac Hypertrophy

Brian S. Manning, PhD; Kyle Shotwell, BA; Lan Mao, MD; Howard A. Rockman, MD; Walter J. Koch, PhD

From the Departments of Surgery (B.S.M., K.S., W.J.K.) and Medicine (L.M., H.A.R.), Duke University Medical Center, Durham, NC. Dr Manning is currently with Obesity Molecular Sciences, CVMD Discovery, Pfizer Global Research and Development, Groton Laboratories, Groton, Conn.

Correspondence to Walter J. Koch, PhD, Duke University Medical Center, Box 2606, Room 472 MSRB, Durham, NC 27710. E-mail koch0002{at}mc.duke.edu

Background—Transgenic mice with constitutive myocardium-targeted expression of a peptide inhibitor of the ß-adrenergic receptor kinase (ßARKct) have increased in vivo cardiac function and enhanced ß-adrenergic receptor (ßAR) responsiveness.

Methods and Results—In the present study, we created transgenic mice with myocardium-targeted ßARKct transgene expression under control of the CARP (cardiac ankyrin repeat protein) promoter, which is active during cardiac development and inactive in the normal adult mouse heart. Consistent with this, adult CARP-ßARKct transgenic mice have normal in vivo cardiac contractility and ßAR responsiveness indistinguishable from their nontransgenic littermates (NLCs). However, because CARP is in a group of fetal genes activated in the adult ventricle during hypertrophy, we subjected animals to transverse aortic constriction (TAC) to induce pressure overload. Seven days after TAC, CARP-ßARKct hearts had elevations in left ventricular mass similar to those in NLCs; however, TAC did induce demonstrable ßARKct expression in the transgenic hearts. TAC in NLC mice resulted in an upregulation of myocardial ßARK1 and a loss of ßAR-mediated inotropic reserve. Importantly, although ßARK1 was increased in the hypertrophic CARP-ßARKct mice, the in vivo loss of ßAR responsiveness was not seen after induced ßARKct expression.

Conclusions—These results demonstrate that acute ßARK1 inhibition can restore lost myocardial ßAR responsiveness and inotropic reserve in vivo. Furthermore, these mice demonstrate the novel utility of the CARP promoter as an inducible element responsive to pathophysiological conditions in the adult heart.


Key Words: receptors, adrenergic, beta • hypertrophy • genetics




This article has been cited by other articles:


Home page
Circ. Res.Home page
S. J. Matkovich, A. Diwan, J. L. Klanke, D. J. Hammer, Y. Marreez, A. M. Odley, E. W. Brunskill, W. J. Koch, R. J. Schwartz, and G. W. Dorn II
Cardiac-Specific Ablation of G-Protein Receptor Kinase 2 Redefines Its Roles in Heart Development and {beta}-Adrenergic Signaling
Circ. Res., October 27, 2006; 99(9): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. A. Nordlie, L. E. Wold, B. Z. Simkhovich, C. Sesti, and R. A. Kloner
Molecular Aspects of Ischemic Heart Disease: Ischemia/Reperfusion-Induced Genetic Changes and Potential Applications of Gene and RNA Interference Therapy
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 17 - 30.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. R. Bridges, K. Gopal, D. E. Holt, C. Yarnall, S. Cole, R. B. Anderson, X. Yin, A. Nelson, B. W. Kozyak, Z. Wang, et al.
Efficient myocyte gene delivery with complete cardiac surgical isolation in situ
J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1364 - 1364.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. W. Holmes
Candidate mechanical stimuli for hypertrophy during volume overload
J Appl Physiol, October 1, 2004; 97(4): 1453 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A Movsesian
Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy
Cardiovasc Res, June 1, 2004; 62(3): 450 - 459.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. L. Williams, J. A. Hata, J. Schroder, E. Rampersaud, J. Petrofski, A. Jakoi, C. A. Milano, and W. J. Koch
Targeted {beta}-Adrenergic Receptor Kinase ({beta}ARK1) Inhibition by Gene Transfer in Failing Human Hearts
Circulation, April 6, 2004; 109(13): 1590 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Torrado, E. Lopez, A. Centeno, A. Castro-Beiras, and A. T. Mikhailov
Left-right asymmetric ventricular expression of CARP in the piglet heart: regional response to experimental heart failure
Eur J Heart Fail, March 1, 2004; 6(2): 161 - 172.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
J.R. Keys and W.J. Koch
The Adrenergic Pathway and Heart Failure
Recent Prog. Horm. Res., January 1, 2004; 59(1): 13 - 30.
[Abstract] [Full Text]


Home page
Physiol. GenomicsHome page
J. G. Dobson, J. Fray, J. L. Leonard, and R. E. Pratt
Molecular mechanisms of reduced {beta}-adrenergic signaling in the aged heart as revealed by genomic profiling
Physiol Genomics, October 17, 2003; 15(2): 142 - 147.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
J. A. Hata and W. J. Koch
Phosphorylation of G Protein-Coupled Receptors: GPCR Kinases in Heart Disease
Mol. Interv., August 1, 2003; 3(5): 264 - 272.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. de Waard, T. A.E. van Achterberg, N. J. Beauchamp, H. Pannekoek, and C. J.M. de Vries
Cardiac Ankyrin Repeat Protein (CARP) Expression in Human and Murine Atherosclerotic Lesions: Activin Induces Carp in Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 64 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Kim, A. D. Eckhart, S. Eguchi, and W. J. Koch
beta -Adrenergic Receptor-mediated DNA Synthesis in Cardiac Fibroblasts Is Dependent on Transactivation of the Epidermal Growth Factor Receptor and Subsequent Activation of Extracellular Signal-regulated Kinases
J. Biol. Chem., August 23, 2002; 277(35): 32116 - 32123.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. F. Steinberg
G protein-coupled receptor kinases: gotta real kure for heart failure?
J. Am. Coll. Cardiol., August 1, 2001; 38(2): 541 - 545.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-J. Du
Sympathoadrenergic mechanisms in functional regulation and development of cardiac hypertrophy and failure: findings from genetically engineered mice
Cardiovasc Res, June 1, 2001; 50(3): 443 - 453.
[Full Text] [PDF]


Home page
Circ. Res.Home page
C. L. Antos, N. Frey, S. O. Marx, S. Reiken, M. Gaburjakova, J. A. Richardson, A. R. Marks, and E. N. Olson
Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A
Circ. Res., November 23, 2001; 89(11): 997 - 1004.
[Abstract] [Full Text] [PDF]